Naglaa A. El-gendy

Soluble Vascular Endothelial Growth Factor and its Soluble Receptor 1 in Patients with Post-Hepatitis C Virus Liver Cirrhosis

M. Ibrahim, N. Elgendy, Naglaa Tawfeek, 2014 .

SP138Egyptian Experience of Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis

H. Mansour, S. Zaky, M. Hegazy, 2019, Nephrology Dialysis Transplantation.

Efficacy of Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis

Sherif A. Nassib, F. El-Raey, N. Elgendy, 2020 .

Inflammatory biomarkers as prognostic indicators of liver cirrhosis

Naglaa Tawfik, R. Saleh, Naglaa A. El-gendy, 2019, Journal of Advanced Research.